In Certain Types of Lung Cancer, Targeted Drug Tagrisso Slashed Recurrence Rates, New Study Says

Published Sep 22, 2020

In Certain Types of Lung Cancer, Targeted Drug Tagrisso Slashed Recurrence Rates, New Study Says

Already approved for EGFR-positive metastatic non-small cell lung cancer, osimertinib (Tagrisso ) brings major benefits in early cancer, too.

NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
A New Option for Some People With Lung Cancer: How This Immunotherapy/Chemotherapy Combo Can Increase Treatment Success
NOW
PLAYING
'The Fight Against Cancer is So Challenging & So Private;' Prostate Cancer Survivor Cal Ripken Jr. on Trey Mancini's Colon Cancer Battle in Exclusive Statement to SurvivorNet
NOW
PLAYING
'Raindrops Keep Fallin' on My Head' Singer B.J. Thomas, 78, Diagnosed with Stage 4 Lung Cancer; 'I Ask All of You for Your Prayers'
NOW
PLAYING
'ENHERTU Has Really Changed Me' — One Breast Cancer Survivor's Incredible Story of Hope and Happiness — A Sponsored Documentary
NOW
PLAYING
How Rush Limbaugh & Elton John Became Friends-- "Life is About Building Bridges, Not Walls"
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.